Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
What is the purpose of this trial?
This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
- Up to 30 Years
- Children's Oncology Group
National Cancer Institute (NCI)
- August 2010
- Last Updated:
- September 9, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT01142427